These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 2128047

  • 1. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users.
    van der Spuy ZM, Sohnius U, Pienaar CA, Schall R.
    Contraception; 1990 Dec; 42(6):597-609. PubMed ID: 2128047
    [Abstract] [Full Text] [Related]

  • 2. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 5. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL, Katz M.
    Contraception; 1979 Nov 15; 20(5):475-87. PubMed ID: 393456
    [Abstract] [Full Text] [Related]

  • 6. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS.
    Contraception; 1998 Jan 15; 57(1):39-44. PubMed ID: 9554249
    [Abstract] [Full Text] [Related]

  • 7. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT.
    Contraception; 1986 Nov 15; 34(5):513-22. PubMed ID: 3102162
    [Abstract] [Full Text] [Related]

  • 8. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, Lähteenmäki P.
    Am J Obstet Gynecol; 1998 Jul 15; 179(1):41-6. PubMed ID: 9704763
    [Abstract] [Full Text] [Related]

  • 9. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul 15; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K, Lunell NO, Zador G.
    Gynecol Obstet Invest; 1978 Jul 15; 9(6):304-11. PubMed ID: 754992
    [Abstract] [Full Text] [Related]

  • 11. The response of the pituitary-ovarian axis to pulsatile administration of gonadotropin-releasing hormone in long-term oral contraceptive users.
    Hemrika DJ, Slaats EH, Schoemaker J.
    Am J Obstet Gynecol; 1994 Feb 15; 170(2):462-8. PubMed ID: 8116698
    [Abstract] [Full Text] [Related]

  • 12. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR, Kletzky OA, Brenner PF, Roy S, Nicoloff J.
    Am J Obstet Gynecol; 1977 May 01; 128(1):60-74. PubMed ID: 403765
    [Abstract] [Full Text] [Related]

  • 13. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J.
    J Clin Endocrinol Metab; 1993 Aug 01; 77(2):420-6. PubMed ID: 8345046
    [Abstract] [Full Text] [Related]

  • 14. The mechanism of action of a new low-dosed combined oral contraceptive.
    Dericks-Tan JS, Schneider K, Taubert HD.
    Arch Gynecol; 1980 Aug 01; 229(2):107-14. PubMed ID: 6768343
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ, Kletzky OA, Brenner PF, Mishell DR.
    Fertil Steril; 1978 Aug 01; 30(2):141-5. PubMed ID: 98356
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
    Jones GE, Wentz AC, Rosenwaks Z, Shoemaker J.
    Am J Obstet Gynecol; 1977 Dec 01; 129(7):760-76. PubMed ID: 343592
    [Abstract] [Full Text] [Related]

  • 19. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive.
    Spellacy WN, Kalra PS, Buhi WC, Birk SA.
    Am J Obstet Gynecol; 1980 May 01; 137(1):109-15. PubMed ID: 6768295
    [Abstract] [Full Text] [Related]

  • 20. Metabolic changes during treatment with two different progestogens.
    Refn H, Kjaer A, Lebech AM, Borggaard B, Schierup L, Bremmelgaard A.
    Am J Obstet Gynecol; 1990 Jul 01; 163(1 Pt 2):374-7. PubMed ID: 2115298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.